Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?
The Motley Fool ·
Bristol Myers trades at under 10 times forward earnings, while Vertex commands nearly triple that multiple, but its margins are roughly double.
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?
Bristol Myers trades at under 10 times forward earnings, while Vertex commands nearly triple that multiple, but its margins are roughly double.
1 sources · 1 articles · updated 2026-11-07 14:37 UTC · business